AKAN
AKANDA (AKAN)
NASDAQ
$5.53+$0.22 (+4.12%)
Price as of Aug 03, 2026 9:01 AM EDT
  • $2.9M
    Market Cap
  • -93.13%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 45
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$5.14
$6.12
$5.31
1-Year Range
$0.45
$57.09
$5.31
Latest Close$5.31
Change
-$1.08 (-20.34%)
Volume89,943
Market Cap$2.9M
Shares Outstanding540,841
P/E (TTM)-0.0004
Diluted EPS (TTM)-$14,899.95
Enterprise Value$3.5M

Information as of 07/31/2026

Company Profile

$2.9M
Market Cap
-$45.7M
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
100 King St. W, Toronto, ON, Canada, M5X 1G5
416 862 7525

Akanda Corp., through its subsidiaries, operates as early-stage cannabis company in Mexico. It is involved in medical cannabis cultivation, manufacturing, and sale; and leasing and/or rental of fiber optic networks and telecommunication towers. The company is based in Toronto, Canada.

Key Executives

  • Katharyn Field
  • Edgar Contreras
  • Gurcharn Deol
  • Francisco Juarez

Current Ownership Distribution

  • Mutual Funds725,529 (50.72%)
  • Institutions697,158 (48.74%)
  • Insiders7,816 (0.55%)
  • Other0 (0.00%)